New Delhi: The World Health Organisation (WHO) has suspended the procurement of Covaxin, produced by Bharat Biotech, through UN agencies, NDTV reported. It said the step has been taken to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection.
The WHO clarified that the vaccine is effective and no safety concerns exist.
Hyderabad-based Bharat Biotech on Sunday said there is “no impact on efficacy and safety of Covaxin”. “For the millions who have received Covaxin, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine,” Bharat Biotech said in the statement, according to ANI.
WHO said the suspension followed an emergency use listing (EUL) inspection conducted from March 14 to 22.
Bhubaneswar: A day before the Pravasi Bharatiya Divas kicks off here, the Global Organization of…
Bhubaneswar: The Capital Region Urban Transport (CRUT) on Tuesday announced launch of two new services…
Hyderabad: Allu Arjun’s ‘Pushpa 2: The Rule’ has broken all box-office records by crossing the…
Dhaka: Bangladesh’s interim government, headed by Nobel Laureate Muhammad Yunus, has revoked the passports of 97…
Dubai: South superstar Ajith Kumar, who is gearing up to participate in the Dubai 24…
New Delhi: Hours after a powerful earthquake jolted Tibet, several aftershocks -- including a 4.1…
This website uses cookies.
